GJIC
AGN

Gamble Jones Investment Counsel’s Allergan Inc AGN Stock Holding History

Gamble Jones Investment Counsel’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,300
Closed -$348K – 209
2016
Q1 		$348K Sell
1,300
-261
-17% -$69.9K 0.04% 175
2015
Q4 		$488K Buy
1,561
+9
+0.6% +$2.81K 0.05% 162
2015
Q3 		$422K Sell
1,552
-30
-2% -$8.16K 0.05% 171
2015
Q2 		$480K Buy
+1,582
New +$480K 0.05% 172
2015
Q1 		– Sell
-4,214
Closed -$896K – 232
2014
Q4 		$896K Hold
4,214
– – 0.09% 135
2014
Q3 		$751K Hold
4,214
– – 0.08% 139
2014
Q2 		$713K Hold
4,214
– – 0.08% 149
2014
Q1 		$523K Hold
4,214
– – 0.06% 158
2013
Q4 		$468K Hold
4,214
– – 0.06% 163
2013
Q3 		$381K Hold
4,214
– – 0.05% 180
2013
Q2 		$355K Buy
+4,214
New +$437K 0.05% 183

Other funds holding AGN

FIM
Frontier Investment Management Dallas, Texas $1.62B AUM 1.86% 1-Year Est. Return
MCM
Mengis Capital Management Portland, Oregon $658M AUM 39.64% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $815M AUM 30.42% 1-Year Est. Return
HHAA
Henry H. Armstrong Associates Pittsburgh, Pennsylvania $1.03B AUM 4.23% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
CI
Chartist Inc Seal Beach, California $139M AUM
SIA
Starfire Investment Advisers Southfield, Michigan $209M AUM 2.6% 1-Year Est. Return
CIS
Connors Investor Services Wyomissing, Pennsylvania $1.08B AUM 31.31% 1-Year Est. Return
MA
Marshwinds Advisory St Simons Island, Georgia $187M AUM 1.79% 1-Year Est. Return

Gamble Jones Investment Counsel's AGN Position: Q2 2016 in Review

Gamble Jones Investment Counsel sold out of Allergan Inc (AGN) in Q2 2016, closing a stake of 1,300 shares — an estimated $348K sold.

Gamble Jones Investment Counsel first reported a position in AGN in Q2 2013 and held it in 11 quarters. The position peaked at $896K in Q4 2014. 13 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Gamble Jones Investment Counsel reported no remaining Allergan Inc position as of Q2 2016 after selling out during the quarter.
  • Gamble Jones Investment Counsel sold 1,300 Allergan Inc shares in Q2 2016, an estimated $348K.
  • Gamble Jones Investment Counsel first reported a position in Allergan Inc in Q2 2013 and held it in 11 quarters.
  • Gamble Jones Investment Counsel's Allergan Inc position peaked at $896K in Q4 2014.
  • 13 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2016.

Based on Gamble Jones Investment Counsel's 13F filing for Q2 2016, filed 9 Aug 2016.